Immunological Aspects of the Pathogenesis of Tumors Associated with Epstein-Barr Virus: Vaccines for Prevention and Therapy
作者： G. Benninger-Döring , H. Wolf
DOI: 10.1159/000060423
关键词:
摘要:
karger.com 
sci-hub.se 参考文章(48)
Hua Lu, Chi-Ming Chu, Tian-Min Huang, Shu-Yan Gu, Li Ruan, Yi-Hong Miao, M. Motz, H. Wolf, First EBV vaccine trial in humans using recombinant vaccinia virus expressing the major membrane antigen. Developments in biological standardization. ,vol. 84, pp. 171- 177 ,(1995)
Nadja S. Prang, Mathias W. Hornef, Michael Jäger, Hans J. Wagner, Hans Wolf, Fritz M. Schwarzmann, Lytic replication of Epstein-Barr virus in the peripheral blood: Analysis of viral gene expression in B lymphocytes during infectious mononucleosis and in the normal carrier state Blood. ,vol. 89, pp. 1665- 1677 ,(1997) , 10.1182/BLOOD.V89.5.1665.1665_1665_1677
R J Tierney, J M Brooks, W A Thomas, S P Lee, A B Rickinson, Conserved CTL epitopes within EBV latent membrane protein 2: a potential target for CTL-based tumor therapy. Journal of Immunology. ,vol. 158, pp. 3325- 3334 ,(1997)
J M Burrows, S R Burrows, L M Poulsen, T B Sculley, D J Moss, R Khanna, Unusually high frequency of Epstein-Barr virus genetic variants in Papua New Guinea that can escape cytotoxic T-cell recognition: implications for virus evolution. Journal of Virology. ,vol. 70, pp. 2490- 2496 ,(1996) , 10.1128/JVI.70.4.2490-2496.1996
P Cresswell, L Cooper, R Khanna, L M Poulsen, S A Thomson, S R Burrows, D J Moss, Class I processing-defective Burkitt's lymphoma cells are recognized efficiently by CD4+ EBV-specific CTLs. Journal of Immunology. ,vol. 158, pp. 3619- 3625 ,(1997)
R Khanna, R W Slade, L Poulsen, D J Moss, S R Burrows, J Nicholls, J M Burrows, Evolutionary dynamics of genetic variation in Epstein-Barr virus isolates of diverse geographical origins: evidence for immune pressure-independent genetic drift. Journal of Virology. ,vol. 71, pp. 8340- 8346 ,(1997) , 10.1128/JVI.71.11.8340-8346.1997
M Rowe, A L Lear, D Croom-Carter, A H Davies, A B Rickinson, Three pathways of Epstein-Barr virus gene activation from EBNA1-positive latency in B lymphocytes. Journal of Virology. ,vol. 66, pp. 122- 131 ,(1992) , 10.1128/JVI.66.1.122-131.1992
Martina Sherritt, Rajiv Khanna, Scott R. Burrows, EBV Structural Antigens, gp350 and gp85, as Targets for Ex Vivo Virus-Specific CTL During Acute Infectious Mononucleosis: Potential Use of gp350/gp85 CTL Epitopes for Vaccine Design Journal of Immunology. ,vol. 162, pp. 3063- 3069 ,(1999)
N. Kienzle, L. Cooper, R. Khanna, S. R. Burrows, Kum Kum Khanna, D. J. Moss, Engagement of CD40 antigen with soluble CD40 ligand up-regulates peptide transporter expression and restores endogenous processing function in Burkitt's lymphoma cells. Journal of Immunology. ,vol. 159, pp. 5782- 5785 ,(1997)
M Khyatti, P C Patel, I Stefanescu, J Menezes, Epstein-Barr virus (EBV) glycoprotein gp350 expressed on transfected cells resistant to natural killer cell activity serves as a target antigen for EBV-specific antibody-dependent cellular cytotoxicity. Journal of Virology. ,vol. 65, pp. 996- 1001 ,(1991) , 10.1128/JVI.65.2.996-1001.1991